Dr. Chris Semsarian, has been selected as the new editor-in-chief of Circulation: Genomic and Precision Medicine, one of 12 scientific journals of the American Heart Association, a leading voluntary health organisation devoted to fighting cardiovascular disease.
Launched in 2008, Circulation: Genomic and Precision Medicine, aims to drive the future of cardiovascular diagnosis and disease management through investigations of clinical genetics and the novel application of precision medicine. The field of cardiovascular genomics and precision medicine entails diagnosing, treating and preventing inherited heart diseases by considering genetic make-up, the environment and lifestyle factors for each patient.
Dr. Semsarian is the Director of the Genetic Heart Disease and Hypertrophic Cardiomyopathy Clinic at Royal Prince Alfred Hospital in Sydney, director of the Australian Genetic Heart Disease Registry and a professor of medicine at the University of Sydney. In 2017, he was recognised as a Member in the General Division of the Order of Australia for significant service to medicine in the field of cardiology as a clinician and educator and for contributions to the community.
Prior to becoming editor-in-chief, Dr. Semsarian served as senior guest editor for the journal. He has published over 250 scientific publications in many of the highest-ranking cardiovascular and general medical journals and has authored best practice guidelines for inherited heart diseases.
Dr. Semsarian plans to initiate many new features including state-of-the-art contemporary reviews, increased prominence of guideline documents, clinical case reports, introduction of visual abstracts and a greater interaction on social media, including Twitter-based ‘tweetorials’ and journal clubs.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
